Clinical Trial Update: Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing perioperative FOLFIRI to adjuvant FOLFIRI in resectable advanced colorectal cancer after oxaliplatin failure; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• FOLFIRI (irinotecan + leucovorin + 5-fluorouracil)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Colorectal Neoplasms, Effects of Chemotherapy | Phase 3 | Status: UNKNOWN